Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
467,3 USD | -1,35% |
|
-1,79% | +14,84% |
17/06 | VERTEX PHARMACEUTICALS INCORPORATED : Argus bevestigt koopadvies | ZM |
14/06 | Vertex Pharmaceuticals zegt dat gen-editing therapie klinische voordelen laat zien in proeven met genetische ziekten | MT |
![Consensus](/images/consensus_flch.gif)
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+14,84% | 121 mld. | |
+18,31% | 112 mld. | |
+2,94% | 22,72 mld. | |
-18,26% | 20,82 mld. | |
-18,47% | 16,66 mld. | |
-42,36% | 16,36 mld. | |
-14,23% | 16,19 mld. | |
-0,68% | 13,17 mld. | |
+21,87% | 11,11 mld. | |
+111,62% | 10,57 mld. |
- Beurs
- Aandelen
- Koers VRTX
- Nieuws Vertex Pharmaceuticals Incorporated
- Transcript : Vertex Pharmaceuticals Incorporated Presents at The JPMorgan 32nd Annual Healthcare Conference, Jan-14-2014 08